Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Nufarm Limited
  6. Summary
    NUF   AU000000NUF3

NUFARM LIMITED

(NUF)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/15
4.69 AUD   -1.88%
10/07Enko, Nufarm Partner on Novel Crop Health Molecules
CI
10/04What you need to know about the coronavirus right now
RE
10/04Australian share close higher as CBA boosts financials
RE
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
4.5 4.6 4.88 4.78 4.69 Last
833568 1049245 1908975 1176268 1870757 Volume
-0.88% +2.22% +6.09% -2.05% -1.88% Change
Estimated financial data (e)
Sales 2021 3 065 M 2 274 M 2 274 M
Net income 2021 43,9 M 32,6 M 32,6 M
Net Debt 2021 385 M 286 M 286 M
P/E ratio 2021 46,8x
Yield 2021 0,29%
Sales 2022 3 108 M 2 306 M 2 306 M
Net income 2022 74,4 M 55,2 M 55,2 M
Net Debt 2022 329 M 244 M 244 M
P/E ratio 2022 24,7x
Yield 2022 1,57%
Capitalization 1 782 M 1 322 M 1 322 M
EV / Sales 2021 0,71x
EV / Sales 2022 0,68x
Nbr of Employees 2 378
Free-Float 75,0%
More Financials
Company
Nufarm Limited is an Australia-based company, which is engaged in development and manufacturing of crop protection solutions and seed technologies. The Company operates through two segments: Crop protection and Seed Technologies. Crop protection segment is engaged in development, manufacturing and sell crop protection solutions including herbicides, insecticides and fungicides, which helps growers protect crops... 
More about the company
Ratings of Nufarm Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about NUFARM LIMITED
10/07Enko, Nufarm Partner on Novel Crop Health Molecules
CI
10/04What you need to know about the coronavirus right now
RE
10/04Australian share close higher as CBA boosts financials
RE
10/03GLAXOSMITHKLINE : Australia sees COVID-19 outbreak levelling off
RE
09/03PRESS RELEASE : crop.zone Sweeps the PotatoEurope Innovation Awards and Wins Two Prizes
DJ
07/22Sydney's COVID-19 outbreak throws harsh spotlight on Australia vaccine rollout
RE
07/22Australia's drug regulator approves Pfizer COVID-19 vaccine for 12 to 15-year-olds
RE
06/16Nufarm Limited Announces Board Changes
CI
05/26STINKWEED TO FALSE FLAX : oilseeds race to reap biofuel bonanza
RE
05/20NUFARM : Half-Year EBITDA More Than Doubles on Higher Revenue, Profit Margins; Shares Down..
MT
05/19Nufarm Limited Reports Earnings Results for the Half Year Ended March 31, 2021
CI
05/13NAB Says Australia's COVID-19 Vaccine Pace Is Trending Higher
MT
05/12Australia seeks deal with Moderna for domestic production of mRNA vaccines
RE
05/12MODERNA : Australia in 'active talks' with Moderna to locally produce mRNA vaccines
RE
05/03ASTRAZENECA : Australia defends decision to sanction travellers from COVID-ravaged India
RE
More news
News in other languages on NUFARM LIMITED
06/17Australia limita el uso de la vacuna de COVID-19 de AstraZeneca a los mayores de 60 año..
06/17STOCK MARKET PARIS : Les valeurs à suivre à Paris et en Europe
05/20MÄRKTE ASIEN/Uneinheitlich - Sydney deutlich erholt
05/20MÄRKTE ASIEN/Uneinheitlich - Stahl- und Rohstoffaktien schwach
04/30Australien plant Haftstrafen für Heimkehrer aus Hochrisikogebieten
More news
Analyst Recommendations on NUFARM LIMITED
More recommendations
Chart NUFARM LIMITED
Duration : Period :
Nufarm Limited Technical Analysis Chart | NUF | AU000000NUF3 | MarketScreener
Technical analysis trends NUFARM LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 4,69 AUD
Average target price 5,60 AUD
Spread / Average Target 19,5%
EPS Revisions
Managers and Directors
Gregory Allan Hunt Chief Executive Officer, Executive Director & MD
Paul Ronald Townsend Chief Financial Officer
John Charles Gillam Chairman
Gordon R. Davis Independent Non-Executive Director
Peter Maxwell Margin Independent Non-Executive Director
Sector and Competitors